Lenalidomide and Arsenic Trioxide Have Independent Non-Interfering Effects When Used in Combination on Myeloma Cell Lines in <i>Vitro</i>

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Lenalidomide and Arsenic Trioxide Have Independent Non-Interfering Effects When Used in Combination on Myeloma Cell Lines in Vitro"
written by Huaquan Wang, Xianghong Chen, Erika A. Eksioglu, Junmin Zhou, Nicole R. Fortenbery, Julie Djeu, Alan List, Sheng Wei,
published by Journal of Cancer Therapy, Vol.4 No.3, 2013

has been cited by the following article(s):

[1]	The role of cereblon in lenalidomide therapy of del (5q) myelodysplastic syndrome
	2022

[2]	VIRALLY-INDUCED HEMATOLOGICAL MALIGNANCIES WITH DISMAL PROGNOSIS: IMPACT OF EPIGENETICS AND POTENTIAL THERAPEUTICS
	2021

[3]	Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma
	2020

[4]	Redox inhibition of Protein Phosphatase PP2A: potential implications in oncogenesis and its progression
	2019

Follow SCIRP